Home
About
Overview
Sharing Data
ORCID
Help
History (3)
Abnormal differentiation of tissue macrophage populations in 'osteopetrosis' (op) mice defective in the production of macrophage colony-stimulating factor.
Efficacy and safety of therapeutic alpha-1-microglobulin RMC-035 in reducing kidney injury after cardiac surgery: a multicentre, randomised, double-blind, parallel group, phase 2a trial.
Interfering with the IFN-?/CXCL10 pathway to develop new targeted treatments for vitiligo.
See All 3 Pages
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Interfering with the IFN-?/CXCL10 pathway to develop new targeted treatments for vitiligo.
Rashighi M, Harris JE. Interfering with the IFN-?/CXCL10 pathway to develop new targeted treatments for vitiligo. Ann Transl Med. 2015 Dec; 3(21):343.
View in:
PubMed
authors with profiles
John E Harris MD, PhD
Mehdi Rashighi Firoozabadi MD